Skip to main content
Premium Trial:

Request an Annual Quote

InformedDNA to Provide Genetic Counseling for Cigna Members

NEW YORK (GenomeWeb News) – InformedDNA today said that it is providing genetic counseling to certain members of health plan Cigna.

St. Petersburg, Fla.-based InformedDNA is providing counseling from board-certified genetics specialists to Cigna members who are at heightened risk for breast cancer, colorectal cancer syndromes, or Long QT syndrome and are considering genetic testing. Such Cigna members will be required to undergo the counseling before having a genetic test done.

"Our approach increases access to genetics specialists who have the training to ensure that every person seeking information about their genetic makeup and health risks receives the best and most personalized information available to get the most appropriate care," InformedDNA CEO David Nixon said in a statement. "This proven model for health care utilization ensures that all Cigna customers have swift access to a board-certified genetics specialist to help them evaluate the potential impact of genetic testing on them and their family members."

Life science investment firm MPM Capital's SunStates Fund earlier this month acquired a minority stake in InformedDNA with a $3 million investment.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.